When we took a closer look at the ratio within the CD142+population, CF patients displayed a higher proportion of CD14+CD16+ monocytes as compared to control and DN patients (42.08 ± 13.17%, 47.88 ± 15.95% and 90.31 ± 1.74% for the controls, DN and CF groups respectively; p < 0.001, Fig. 1G). Here, F3 is linked to cystic fibrosis.